Medical Advisory Board

At CR&T, our activities and funding objectives are guided by the expertise of our Medical Advisory Board (MAB), comprising some of the world’s foremost physician-scientists specializing in cancer research.

Advisory board members are widely recognized for their contributions to research in various types of blood cancers, including the myeloproliferative neoplasms (MPNs), leukemia, non-Hodgkin’s lymphoma, Hodgkin’s disease, and multiple myeloma.   Other MAB members are known for their contributions to breast and lung cancer.

The current CR&T Medical Advisory Board members are: